Bristol Myers Squibb (NYSE: BMY) expands Opdivo into frontline Hodgkin lymphoma, strengthening immuno-oncology leadership
Bristol Myers Squibb expands Opdivo in Hodgkin lymphoma. Discover how this reshapes treatment strategy, competition, and long-term oncology trends.
India’s energy security under threat: What drove PM Modi’s emergency cabinet review on West Asia
PM Modi chairs emergency review on petroleum, gas, power and fertiliser supply as Strait of Hormuz disruption cuts LNG flows and halves urea plant output in India.
Patel Retail hits 50-store milestone as PATELRMART trades well below IPO-era highs
Patel Retail opens its 50th Patel's R Mart store in Thakurli, MMR. Read what the milestone means for PATELRMART investors and India's value retail sector.
X-energy files for Nasdaq IPO as Talen Energy partnership broadens its nuclear power case
X-energy has filed for a Nasdaq IPO as it expands SMR ambitions with Talen Energy. Read what the move means for nuclear power, PJM, and investors.
Pawan Kalyan’s Ustaad Bhagat Singh faces box office pressure as Dhurandhar 2 dominates screens
Ustaad Bhagat Singh grosses Rs 71.67 crore worldwide in three days amid a contested release window with Dhurandhar 2, with India net collections at Rs 52.90 crore and profitability contingent on Sunday hold.
Blasts rock central Israel as Iran targets US base near Baghdad airport on day 23
Iran fires ballistic missiles and cluster munitions at central Israel and launches drone strikes on the United States military compound near Baghdad International Airport on March 22, 2026.
Israel’s nuclear city hit: Iran missiles reach Indian Ocean as war enters new phase
Iran strikes Dimona and Arad near Israel's nuclear site and fires long-range missiles at Diego Garcia, wounding 130+ in the conflict's fourth week.
Trump threatens to obliterate Iran power plants unless Strait of Hormuz fully reopens within 48 hours
Trump threatens to obliterate Iran's power plants within 48 hours if the Strait of Hormuz remains closed, as Iranian missiles strike Dimona, Arad, and Diego Garcia.
Aelis Farma’s AEF0217 enters critical Phase 2B trial—can it become the first drug for Down syndrome cognition?
Aelis Farma launches Phase 2B trial for AEF0217 in Down syndrome—could this CB1-targeting drug finally deliver a breakthrough? Read more.
South Korea factory fire kills 14 at Anjun Industrial plant in Daejeon’s Daedeok district
Fourteen people were killed and 59 injured after an explosion and fire destroyed the Anjun Industrial auto parts factory in Daejeon, South Korea, on 20 March 2026.